Digital Behavior Change Interventions for the Prevention and Management of Type 2 Diabetes: Systematic Market Analysis
Journal of Medical Internet Research2021Vol. 24(1), pp. e33348–e33348
Citations Over TimeTop 10% of 2021 papers
Roman Keller, Sven Hartmann, Gisbert Wilhelm Teepe, Kim-Morgaine Lohse, Aishah Alattas, Lorainne Tudor Car, Falk Müller‐Riemenschneider, Florian von Wangenheim, Jacqueline L. Mair, Tobias Kowatsch
Abstract
Our findings suggest that the level of funding received by companies offering DBCIs for type 2 diabetes prevention and management does not coincide with the level of evidence on the intervention effectiveness. There is considerable variation in the level of evidence underpinning the different DBCIs and an overall need for more rigorous effectiveness trials and transparent reporting by quality assurance authorities. Currently, very few DBCIs use automated approaches such as CAs and JITAIs, limiting the scalability and reach of these solutions.
Related Papers
- → Effective implementation of research into practice: an overview of systematic reviews of the health literature(2011)245 cited
- → Interventions for physician burnout: A systematic review of systematic reviews(2018)62 cited
- → Pharmacy-supported interventions at transitions of care: an umbrella review(2019)17 cited
- → An overview of interventions used across the life span to support transitions of those with a neurological condition: A systematic review of reviews(2023)3 cited
- → Impact of Complex Quality-Interventions on Patient Outcome: A Systematic Overview of Systematic Reviews(2019)2 cited